Skip to main content
. 2018 Oct 29;8(2):e1532763. doi: 10.1080/2162402X.2018.1532763

Figure 2.

Figure 2.

Effects of ONCOS-102 and pembrolizumab on annexin V (A) and propidium iodide staining (B) in human melanoma cell lines after 72 h (A375, SK-Mel-2) and 96 h (A2058, SK-Mel-28). Data are expressed as percentage of cells staining positive. Analyses were performed in one replicate experiment.